Phosphorus-32, a clinically available drug, inhibits cancer growth by inducing DNA double-strand breakage

Research output: Research - peer-reviewArticle

Abstract

Radioisotopes that emit electrons (beta particles), such as radioiodine, can effectively kill target cells, including cancer cells. Aqueous 32P[PO4] is a pure beta-emitter that has been used for several decades to treat non-malignant human myeloproliferative diseases. 32P [PO4] was directly compared to a more powerful pure beta-emitter, the clinically important 90Y isotope. In vitro, 32P[PO4] was more effective at killing cells than was the more powerful isotope 90Y (P ≤ 0.001) and also caused substantially more double-stranded DNA breaks than did 90Y. In vivo, a single low-dose intravenous dose of aqueous elemental 32P significantly inhibited tumor growth in the syngeneic murine cancer model (P ≤ 0.001). This effect is exerted by direct incorporation into nascent DNA chains, resulting in double-stranded breakage, a unique mechanism not duplicatable by other, more powerful electron-emitting radioisotopes. 32P[PO4] should be considered for human clinical trials as a potential novel anti-cancer drug.

LanguageEnglish (US)
Article number0128152
JournalPLoS One
Volume10
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

radionuclides
isotopes
electrons
phosphorus
drugs
neoplasms
DNA
dosage
water
cells
Phosphorus
Growth
Pharmaceutical Preparations
Neoplasms
Radioisotopes
Isotopes
Electrons
antineoplastic agents
clinical trials
mice

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Phosphorus-32, a clinically available drug, inhibits cancer growth by inducing DNA double-strand breakage. / Cheng, Yulan; Kiess, Ana P.; Herman, Joseph M.; Pomper, Martin G.; Meltzer, Stephen J.; Abraham, John M.

In: PLoS One, Vol. 10, No. 6, 0128152, 01.06.2015.

Research output: Research - peer-reviewArticle

@article{56461fa64fd84952990db0b28a3ef09e,
title = "Phosphorus-32, a clinically available drug, inhibits cancer growth by inducing DNA double-strand breakage",
abstract = "Radioisotopes that emit electrons (beta particles), such as radioiodine, can effectively kill target cells, including cancer cells. Aqueous 32P[PO4] is a pure beta-emitter that has been used for several decades to treat non-malignant human myeloproliferative diseases. 32P [PO4] was directly compared to a more powerful pure beta-emitter, the clinically important 90Y isotope. In vitro, 32P[PO4] was more effective at killing cells than was the more powerful isotope 90Y (P ≤ 0.001) and also caused substantially more double-stranded DNA breaks than did 90Y. In vivo, a single low-dose intravenous dose of aqueous elemental 32P significantly inhibited tumor growth in the syngeneic murine cancer model (P ≤ 0.001). This effect is exerted by direct incorporation into nascent DNA chains, resulting in double-stranded breakage, a unique mechanism not duplicatable by other, more powerful electron-emitting radioisotopes. 32P[PO4] should be considered for human clinical trials as a potential novel anti-cancer drug.",
author = "Yulan Cheng and Kiess, {Ana P.} and Herman, {Joseph M.} and Pomper, {Martin G.} and Meltzer, {Stephen J.} and Abraham, {John M.}",
year = "2015",
month = "6",
doi = "10.1371/journal.pone.0128152",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "6",

}

TY - JOUR

T1 - Phosphorus-32, a clinically available drug, inhibits cancer growth by inducing DNA double-strand breakage

AU - Cheng,Yulan

AU - Kiess,Ana P.

AU - Herman,Joseph M.

AU - Pomper,Martin G.

AU - Meltzer,Stephen J.

AU - Abraham,John M.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Radioisotopes that emit electrons (beta particles), such as radioiodine, can effectively kill target cells, including cancer cells. Aqueous 32P[PO4] is a pure beta-emitter that has been used for several decades to treat non-malignant human myeloproliferative diseases. 32P [PO4] was directly compared to a more powerful pure beta-emitter, the clinically important 90Y isotope. In vitro, 32P[PO4] was more effective at killing cells than was the more powerful isotope 90Y (P ≤ 0.001) and also caused substantially more double-stranded DNA breaks than did 90Y. In vivo, a single low-dose intravenous dose of aqueous elemental 32P significantly inhibited tumor growth in the syngeneic murine cancer model (P ≤ 0.001). This effect is exerted by direct incorporation into nascent DNA chains, resulting in double-stranded breakage, a unique mechanism not duplicatable by other, more powerful electron-emitting radioisotopes. 32P[PO4] should be considered for human clinical trials as a potential novel anti-cancer drug.

AB - Radioisotopes that emit electrons (beta particles), such as radioiodine, can effectively kill target cells, including cancer cells. Aqueous 32P[PO4] is a pure beta-emitter that has been used for several decades to treat non-malignant human myeloproliferative diseases. 32P [PO4] was directly compared to a more powerful pure beta-emitter, the clinically important 90Y isotope. In vitro, 32P[PO4] was more effective at killing cells than was the more powerful isotope 90Y (P ≤ 0.001) and also caused substantially more double-stranded DNA breaks than did 90Y. In vivo, a single low-dose intravenous dose of aqueous elemental 32P significantly inhibited tumor growth in the syngeneic murine cancer model (P ≤ 0.001). This effect is exerted by direct incorporation into nascent DNA chains, resulting in double-stranded breakage, a unique mechanism not duplicatable by other, more powerful electron-emitting radioisotopes. 32P[PO4] should be considered for human clinical trials as a potential novel anti-cancer drug.

UR - http://www.scopus.com/inward/record.url?scp=84935019676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84935019676&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0128152

DO - 10.1371/journal.pone.0128152

M3 - Article

VL - 10

JO - PLoS One

T2 - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 6

M1 - 0128152

ER -